Drug Trial Radar · NCT07734649
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,400
Planned (sponsor's estimate)
Start
Jul 22, 2026
Primary completion
May 3, 2028
Study completion May 3, 2028
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jul 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is a Phase 1/2, randomized, observer-blind, active and placebo-controlled, multi-center study to be conducted in approximately 2400 adults 60 years of age and older. The aim of the study is to evaluate the immunogenicity and safety of an RSV+HMPV vaccine candidate for the prevention of RSV and HMPV disease among adults 60 years of age and older. While there are 3 FDA approved/licensed RSV vaccines currently available to the public, no vaccine is available for the prevention of HMPV in older adults. This study is intended to provide data in support of further clinical development of the RSV+HMPV vaccine candidate. The study will consist of 4 cohorts and 11 vaccine groups (RSV+HMPV \[6 dose levels\], placebo and 4 control groups). The duration of the study will be approximately 12 months for each participant.
Conditions
- Respiratory Syncytial Virus Immunization
- Human Metapneumovirus Immunization
- Healthy Volunteers
Interventions
RSV+HMPV vaccineBiological
RSV + HMPV Candidate Vaccine
Control Vaccine 3Biological
Control Vaccine 3
Control Vaccine 4Biological
Control Vaccine 4
Control Vaccine 2Biological
Control Vaccine 2
PlaceboOther
Placebo
Control Vaccine 1Biological
Control Vaccine 1
Primary outcomes
What the sponsor says the trial is designed to measure.
- RSV A serum nAb (neutralizing antibodies) titersTime frame: At Day 1 and Day 29
- RSV B serum nAb titersTime frame: At Day 1 and Day 29
- HMPV A serum nAb titersTime frame: At Day 1 and Day 29
- HMPV B serum nAb titersTime frame: At Day 1 and Day 29
- Unsolicited systemic Adverse Events (AEs) that occur within 30 minutes after vaccinationTime frame: Within 30 minutes after vaccination
- Presence of solicited injection site and systemic reactionsTime frame: For 8 days, including the day of vaccination
- Presence of Unsolicited AEsTime frame: For 28 days, including day of vaccination
- Presence of medically attended AEs (MAAEs)Time frame: Within 6 months after vaccination
- Presence of Serious Adverse Events (SAEs) and Adverse Events of Special Interest (AESIs)Time frame: Throughout the study (approximately 12 months)
- Presence of out-of-range biological test resultsTime frame: At Day 09
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
Hawthorne Health - Gadsden- Site Number : 8400025
Gadsden, Alabama · Recruiting
Accel Research Sites Network - Birmingham- Site Number : 8400065
Vestavia Hills, Alabama · Recruiting
Marvel Clinical Research- Site Number : 8400006
Huntington Beach, California · Recruiting
Velocity Clinical Research - San Diego- Site Number : 8400019
La Mesa, California · Recruiting
Long Beach Research Institute- Site Number : 8400005
Long Beach, California · Recruiting
Acclaim Clinical Research- Site Number : 8400033
San Diego, California · Recruiting
Velocity Clinical Research - Washington DC- Site Number : 8400021
Washington D.C., District of Columbia · Recruiting
Accel Research Sites Network - DeLand Clinical Research Unit- Site Number : 8400064
DeLand, Florida · Recruiting
Velocity Clinical Research - New Smyrna Beach- Site Number : 8400017
Edgewater, Florida · Recruiting
Accel Research Sites - Lakeland Clinical Research Unit- Site Number : 8400073
Lakeland, Florida · Recruiting
Accel Research Sites - St. Petersburg - Largo- Site Number : 8400067
Largo, Florida · Recruiting
Accel Research Sites - Maitland Clinical Research Unit- Site Number : 8400074
Maitland, Florida · Recruiting
Alcanza - Innovation Medical Research Center - Palmetto- Site Number : 8400069
Palmetto Bay, Florida · Recruiting
Accel Research Sites - NeuroStudies- Site Number : 8400063
Decatur, Georgia · Recruiting
North Georgia Clinical Research- Site Number : 8400078
Woodstock, Georgia · Recruiting
DM Clinical Research - Chicago- Site Number : 8400050
Melrose Park, Illinois · Recruiting
Enspire Clinical Research- Site Number : 8400077
Peoria, Illinois · Recruiting
DM Clinical Research - Indianapolis- Site Number : 8400082
Indianapolis, Indiana · Recruiting
Velocity Clinical Research - New Orleans- Site Number : 8400022
New Orleans, Louisiana · Recruiting
Boston Clinical Trials- Site Number : 8400070
Boston, Massachusetts · Recruiting
DM Clinical Research - Brookline- Site Number : 8400055
Brookline, Massachusetts · Recruiting
ActivMed Practices & Research - Methuen- Site Number : 8400066
Methuen, Massachusetts · Recruiting
QUEST Research Institute- Site Number : 8400068
Farmington Hills, Michigan · Recruiting
DM Clinical Research - Detroit- Site Number : 8400049
Southfield, Michigan · Recruiting
Velocity Clinical Research - Lincoln - Valley Road- Site Number : 8400016
Lincoln, Nebraska · Recruiting
Velocity Clinical Research - Omaha- Site Number : 8400012
Omaha, Nebraska · Recruiting
Alliance Clinical - Las Vegas- Site Number : 8400034
Las Vegas, Nevada · Recruiting
DM Clinical Research - New Jersey- Site Number : 8400044
Jersey City, New Jersey · Recruiting
Hawthorne - Bienstar Lindenwold- Site Number : 8400027
Lindenwold, New Jersey · Recruiting
DM Clinical Research - Albuquerque- Site Number : 8400051
Albuquerque, New Mexico · Recruiting
Hawthorne Health - Staten Island- Site Number : 8400026
Staten Island, New York · Recruiting
Velocity Clinical Research - Cleveland- Site Number : 8400024
Beachwood, Ohio · Recruiting
Velocity Clinical Research - Springdale- Site Number : 8400014
Cincinnati, Ohio · Recruiting
DM Clinical Research - Philadelphia- Site Number : 8400046
Philadelphia, Pennsylvania · Recruiting
Velocity Clinical Research - Providence- Site Number : 8400018
East Greenwich, Rhode Island · Recruiting
Coastal Carolina Research Center - North Charleston- Site Number : 8400061
North Charleston, South Carolina · Recruiting
Velocity Clinical Research - Austin- Site Number : 8400013
Austin, Texas · Recruiting
Zenos Clinical Research- Site Number : 8400032
Dallas, Texas · Recruiting
DM Clinical Research - CyFair Clinical Research Center- Site Number : 8400058
Houston, Texas · Recruiting
Texas Center for Drug Development - Houston- Site Number : 8400043
Houston, Texas · Recruiting
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.